The Women's Antioxidant and folic acid cardiovascular Study (WAFACS) joined HOPE-2, NORVIT, and VISP in failing to show any benefit of folic acid on cardiovascular events.
女性抗氧化剂和叶酸心血管研究参与了HOPE - 2,NORVIT以及VISP试验，未能显示叶酸在心血管病发病方面有任何作用。
The Women's Antioxidant and folic acid cardiovascular Study (WAFACS) joined HOPE-2, NORVIT, and VISP in failing to show any benefit of folic acid on cardiovascular events.
女性抗氧化剂和叶酸心血管研究参与了HOPE - 2,NORVIT以及VISP试验，未能显示叶酸在心血管病发病方面有任何作用。
应用推荐